secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001104659-25-002876
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical appoints Laura King to Board of Directors effective Jan 13, 2025
--------------------------------------------------------------------------------

- Laura King elected to Board; serves on Audit and Compliance & Reimbursement Committees.
- King brings 22-year GE Healthcare tenure as President & CEO of Global Interventional Business.
- Initial RSU grant valued at pro rata portion of $145,000, vesting earlier of one year or 2025 annual meeting.
- Annual cash retainers: $50,000 board, $10,000 audit committee, $5,000 compliance committee.
- King also co-founder & CEO of BiaCure; formerly led NeuWave Medical (acquired by J&J).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000110465925002876/0001104659-25-002876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000110465925002876/tm253038d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer